The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Die Zahl der Patienten mit Vorhofflimmern (VHF) steigt mit zunehmender Alterung der Bevölkerung. Auch die Zahl der Patienten mit VHF und Indikation für eine orale Antikoagulation (OAK) zur Schlaganfallprävention, die aufgrund eines akuten Koronarsyndroms (ACS) oder einer perkutanen Koronarintervention (PCI) eine duale antithrombozytäre Therapie (DAPT) mit Acetylsalicylsäure (ASS) und einem P2Y12-Inhibitor...
To study the safety and efficacy of the thrombolytic agent saruplase as a bolus, the angiographic and clinical outcomes of three bolus regimens were investigated in a pilot study conducted in 192 patients with an acute myocardial infarction and were compared with the standard regimen. Fifty-two patients received a double bolus of 40 mg and 40 mg after 30 minutes, 51 patients a bolus of 80 mg, and...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.